Long‐term survival analysis of patients with primary Sjögren's syndrome in China: A multicenter retrospective cohort study
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15284 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Li Yueting und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Cause of Death. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Chinese National Key Technology R&D Program, Ministry of Science and Technology, CAMS Innovation Fund for Medical Sciences (CIFMS).
Abstract (Originalsprache)
Aim
This study aimed to evaluate the long‐term survival, causes of death, and prognostic factors in Chinese patients with primary Sjögren syndrome (pSS).
Methods
We included patients with pSS registered in the Chinese Rheumatism Data Centre between May 2016 and December 2021, and collected baseline clinical, laboratory, and treatment data. Survival and standard mortality rates were calculated using general population mortality data. Factors related to mortality were identified using Cox proportional hazards regression.
Results
Among the 8588 patients included, 274 died during a median follow‐up of 4.0 years. The overall standardized mortality ratio was 1.61 (95% CI: 1.43–1.81). Overall survival rates were 98.2% at 5 years and 93.8% at 10 years. The predominant causes of death were comorbidities, including cardiovascular diseases, tumors, and infections, while the most frequent pSS‐related causes of death were interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH). Male sex, older age, ILD, PAH, and high EULAR Sjögren's syndrome disease activity index (ESSDAI), thrombocytopenia, anemia, high immunoglobulin A (IgA) level, and glucocorticoid treatment independently increased the mortality risk, while using hydroxychloroquine was a protective factor.
Conclusion
Mortality rates have significantly increased in Chinese patients with pSS. Comorbidities, rather than pSS‐related organ damage, were the main causes of death. All‐cause mortality was associated with male sex, older age, ILD, PAH, high ESSDAI, thrombocytopenia, anemia, high IgA level, and glucocorticoid treatment, whereas hydroxychloroquine use might improve the long‐term survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China.
- Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
- National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital,…
- Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
- Department of Rheumatology and Immunology, The First Affiliated Hospital of Kunming Medical University, Kunming, PR China.
- Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
ORCID-Profile: Li Yueting, Kong Xiaodan, Zhao Jiuliang, Xu Dong
Förderung
- Chinese National Key Technology R&D Program
- Ministry of Science and Technology
- CAMS Innovation Fund for Medical Sciences (CIFMS)
- National High-Level Hospital Clinical Research Funding
Zitieren
APA
Yueting, L., Lin, Q., Jian, X., Xinwang, D., Yongfu, W., Weiguo, X., Xiaodan, K., Qin, L., Songlou, Y., Liyun, Z., Lijun, W., Chanyuan, W., Jiuliang, Z., Yanhong, W., Siyun, C., Dong, X., Mengtao, L., Xiaofeng, Z., & Yan, Z. (2024). Long‐term survival analysis of patients with primary Sjögren's syndrome in China: A multicenter retrospective cohort study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15284
Vancouver
Yueting L, Lin Q, Jian X, Xinwang D, Yongfu W, Weiguo X, et al. Long‐term survival analysis of patients with primary Sjögren's syndrome in China: A multicenter retrospective cohort study. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15284
BibTeX
@article{Yueting2024,
author = {Yueting, Li and Lin, Qiao and Jian, Xu and Xinwang, Duan and Yongfu, Wang and Weiguo, Xiao and Xiaodan, Kong and Qin, Li and Songlou, Yin and Liyun, Zhang and Lijun, Wu and Chanyuan, Wu and Jiuliang, Zhao and Yanhong, Wang and Siyun, Chen and Dong, Xu and Mengtao, Li and Xiaofeng, Zeng and Yan, Zhao},
title = {Long‐term survival analysis of patients with primary Sjögren's syndrome in China: A multicenter retrospective cohort study},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15284}
}
EUVIMED